Related Experiment Video
Updated: Feb 15, 2026

Author Spotlight: Optimizing Antibody-Based Cancer Treatments via Antibody-Dependent, Cell-Mediated Cytotoxicity Assay
Published on: September 13, 2024
miR-328 mediates a metabolic shift in colon cancer cells by targeting SLC2A1/GLUT1
S Santasusagna1, I Moreno2, A Navarro1
1Molecular Oncology and Embryology Laboratory, Human Anatomy Unit, School of Medicine, University of Barcelona, IDIBAPS, Barcelona, Spain.
Purpose:
Increasing evidence shows that altered metabolism is a critical hallmark in colon cancer. There is a strong need to explore the molecular mechanisms underlying cancer metabolism. Whether the aberrant expression of microRNAs contributes to cancer metabolism is not fully understood. miR-328 is a putative potential target of SLC2A1, but the regulating mechanism between them remains unknown. We have examined whether miR-328 directly regulates SLC2A1/GLUT1 expression in colon cancer cells.
Methods:
We performed in silico bioinformatic analyses to identify miR-328-mediated molecular pathways and targets. We also performed luciferase assays and western blot analyses in LOVO and SW480 colon cancer cell lines. In addition, we assessed miR-328 expression in 47 paired tumor and normal tissue specimens from resected colon cancer patients.
Results:
Luciferase reporter assays showed that miR-328 directly targeted SLC2A1 3'-untranslated region (UTR), with a significant decrease in luciferase activity in both LOVO and SW480 cell lines. These results were validated by western blot. miR-328 expression was significantly downregulated in tumor tissue compared with paired normal tissue.
Conclusions:
Our results show that miR-328 targets SLC2A1/GLUT1. We suggest that miR-328 may be involved in the orchestration of the Warburg effect in colon cancer cells. Furthermore, miR-328 expression is reduced in colon cancer patients and thus inversely correlates with the classically reported upregulated SLC2A1/GLUT1 expression in tumors.
Insights
MicroRNA-328 directly targets SLC2A1/GLUT1, a key player in colon cancer metabolism. This microRNA is downregulated in colon tumors, suggesting its role in the Warburg effect.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Metabolism
Background:
- Altered cellular metabolism is a hallmark of colon cancer.
- The role of microRNAs in regulating cancer metabolism requires further investigation.
- SLC2A1 (Solute Carrier Family 1, Member 1), also known as GLUT1, is implicated in cancer metabolism.
Purpose of the Study:
- To investigate whether microRNA-328 (miR-328) directly regulates SLC2A1/GLUT1 expression in colon cancer cells.
- To explore the role of miR-328 in colon cancer metabolism.
- To determine the expression levels of miR-328 in colon tumor tissues.
Main Methods:
- In silico bioinformatic analyses to identify miR-328 targets and pathways.
- Luciferase reporter assays and Western blot analyses in LOVO and SW480 colon cancer cell lines.
- Assessment of miR-328 expression in 47 paired colon tumor and normal tissue specimens.
Main Results:
- Luciferase assays confirmed direct targeting of the SLC2A1 3'-untranslated region (UTR) by miR-328, leading to decreased luciferase activity.
- Western blot analysis validated the regulatory effect of miR-328 on SLC2A1/GLUT1 expression.
- miR-328 expression was significantly downregulated in colon tumor tissues compared to adjacent normal tissues.
Conclusions:
- miR-328 directly targets and regulates SLC2A1/GLUT1 expression in colon cancer.
- Downregulation of miR-328 in colon cancer may contribute to the Warburg effect.
- miR-328 represents a potential biomarker and therapeutic target in colon cancer, inversely correlating with SLC2A1/GLUT1 upregulation.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
The Colonization of Land
What is Metabolism?
Receptor-mediated Endocytosis
Cell-mediated Immune Responses
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...

